Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan 20:7:697.
doi: 10.3389/fimmu.2016.00697. eCollection 2016.

Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential

Affiliations
Review

Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential

Wendy Dankers et al. Front Immunol. .

Abstract

Over the last three decades, it has become clear that the role of vitamin D goes beyond the regulation of calcium homeostasis and bone health. An important extraskeletal effect of vitamin D is the modulation of the immune system. In the context of autoimmune diseases, this is illustrated by correlations of vitamin D status and genetic polymorphisms in the vitamin D receptor with the incidence and severity of the disease. These correlations warrant investigation into the potential use of vitamin D in the treatment of patients with autoimmune diseases. In recent years, several clinical trials have been performed to investigate the therapeutic value of vitamin D in multiple sclerosis, rheumatoid arthritis, Crohn's disease, type I diabetes, and systemic lupus erythematosus. Additionally, a second angle of investigation has focused on unraveling the molecular pathways used by vitamin D in order to find new potential therapeutic targets. This review will not only provide an overview of the clinical trials that have been performed but also discuss the current knowledge about the molecular mechanisms underlying the immunomodulatory effects of vitamin D and how these advances can be used in the treatment of autoimmune diseases.

Keywords: B cells; T cells; autoimmune disease; dendritic cells; macrophages; supplementation; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Vitamin D metabolism. The metabolic pathway of vitamin D. Red arrows indicate inhibition, and green arrows indicate induction.
Figure 2
Figure 2
The anti-inflammatory effects of 1,25(OH)2D3 on cells of the immune system. An overview of the anti-inflammatory effects of 1,25(OH)2D3 on the cells of the immune system in autoimmunity. Red dots represent pro-inflammatory cytokines, while green dots represent anti-inflammatory cytokines. Red arrows indicate decreased differentiation, and green arrows indicate increased differentiation. References: CD8+ T cells (–81); innate lymphoid cells (–86); unconventional T cells (–89); B cells (, –96); dendritic cells (–103); macrophages (–108); CD4+ T cells (–125).

Similar articles

Cited by

References

    1. Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis (2015) 3(4):151–5.10.12691/ijcd-3-4-8 - DOI
    1. Chang C. Unmet needs in the treatment of autoimmunity: from aspirin to stem cells. Autoimmun Rev (2014) 13(4–5):331–46.10.1016/j.autrev.2014.01.052 - DOI - PubMed
    1. Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Endocrinol Metab Clin North Am (2010) 39(2):243–53.10.1016/j.ecl.2010.02.002 - DOI - PMC - PubMed
    1. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am (2010) 39(2):255–69.10.1016/j.ecl.2010.02.007 - DOI - PMC - PubMed
    1. Heikkinen S, Vaisanen S, Pehkonen P, Seuter S, Benes V, Carlberg C. Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res (2011) 39(21):9181–93.10.1093/nar/gkr654 - DOI - PMC - PubMed